IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Nidan Laboratories and Healthcare IPO is a Fixed Price IPO listing on NSE EMERGE exchange. The company is based in Palagar and caters to Healthcare - Hospitals And Clinic sector. First Overseas Capital is the merchant banker of Nidan Laboratories and Healthcare IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 23rd October 2021.
Nidan Laboratories and Healthcare IPO open date is 28th October 2021 and close date is 2nd November 2021. IPO Allotment Date is 9th November 2021 and Listing date is 12th November 2021.
IPO
Size:
₹ 50.00 Cr.
Avg IPO Size (Sector Based)
: ₹
35.35 cr.
Sector: Healthcare - Hospitals And Clinic
SME
IPO so far:
13
Merchant Banker:
First Overseas
SME
IPO by BRLM so far:
51
City:
Palagar
SME
IPO so far:
1
Revenue (annualised):
₹
31.40
cr. 
PE
Ratio:
39.81x
Average Sector PE Ratio: 24.63x
Nidan Laboratories and Healthcare IPO size is ₹ 50.00 Cr. with IPO price of ₹ 125.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
First Overseas Capital Limited is the book-running lead manager of the Nidan Laboratories and Healthcare IPO. Bigshare Services Private Limited is the Registrar and Market Maker is NNM Securities Private Limited for Nidan Laboratories and Healthcare IPO.
Nidan Laboratories and Healthcare IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Nidan Laboratories and Healthcare IPO, based in Palagar, operates in the Healthcare - Hospitals And Clinic sector with a focus on Healthcare service provider. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Nidan Laboratories and Healthcare IPO size is ₹ 50.00 Cr. with fresh issue size of ₹ 50.00 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Nidan Laboratories and Healthcare IPO is expected to be 9th November 2021, after the finalization of basis of allotment. Investors can check Nidan Laboratories and Healthcare IPO allotment status on the registrars website, Bigshare Services Private Limited. Nidan Laboratories and Healthcare IPO refund dates are 10th November 2021.
Nidan Laboratories and Healthcare IPO is expected to be listed on 12th November 2021.
The upper price band for the Nidan Laboratories and Healthcare IPO is set at ₹ 125.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Nidan Laboratories and Healthcare IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Nidan Laboratories and Healthcare IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 2nd November 2021. After submission, funds are blocked until the basis of allotment of Nidan Laboratories and Healthcare IPO is finalised.
The merchant banker for Nidan Laboratories and Healthcare IPO is First Overseas Capital Limited . First Overseas Capital Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Nidan Laboratories and Healthcare IPO RHP for further details.
The registrar for Nidan Laboratories and Healthcare IPO is Bigshare Services Private Limited. Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Nidan Laboratories and Healthcare IPO through their official website or helpline.
Nidan Laboratories and Healthcare IPO was subscribed 1.80 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 50.00 Cr.
Avg IPO Size (Sector Based)
:
₹ 35.35 Cr.
Sector: Healthcare - Hospitals And Clinic
SME
IPO so far:
13
Merchant Banker:
First Overseas
SME
IPO by BRLM so far:
51
City:
Palagar
SME
IPO so far:
1
Revenue (annualised):
₹ 31.32 cr.
PE
Ratio:
39.81x
Average Sector PE Ratio: 24.63x
Nidan Laboratories and Healthcare IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Nidan Laboratories and Healthcare Financial Review Page
Merchant Banker(s) of Nidan Laboratories and Healthcare IPO: First Overseas Capital Limited
Nidan Laboratories and Healthcare IPO subscription was 1.80 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Nidan Laboratories and Healthcare IPO listed at a listing price of 117.75 against the offer price of 125.00.
The current market price of Nidan Laboratories and Healthcare is 20.00.
Why Us?
